228 related articles for article (PubMed ID: 12203166)
21. Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy.
Moskovitz M; Bartlett JG
Arch Intern Med; 1981 Apr; 141(5):663-4. PubMed ID: 7224749
[TBL] [Abstract][Full Text] [Related]
22. Rifaximin in the treatment of recurrent Clostridium difficile infection.
Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
[TBL] [Abstract][Full Text] [Related]
23. Update on Clostridium difficile-induced colitis, Part 2.
Reinke CM; Messick CR
Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
25. [A case of pseudomembranous colitis with febrile neutropenia induced by chemotherapy and effectively treated by vancomycin enemas].
Tsuchida K; Hayashi T; Hayashi S; Sawazaki S; Jin Y; Hasuo K; Suzuki H; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1821-3. PubMed ID: 20841956
[TBL] [Abstract][Full Text] [Related]
26. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
El-Herte RI; Baban TA; Kanj SS
Scand J Infect Dis; 2012 Mar; 44(3):228-30. PubMed ID: 22077098
[TBL] [Abstract][Full Text] [Related]
27. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
[TBL] [Abstract][Full Text] [Related]
28. [Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
Tordjman R; Benfiguig K; Eugène C; Mitry E; Merrer J
Gastroenterol Clin Biol; 1995 May; 19(5):545-6. PubMed ID: 7590012
[No Abstract] [Full Text] [Related]
29. Basic and clinical aspects of Clostridium difficile colitis.
Morishita T; Nakayama T; Kamiya T; Mori S; Isobe K; Furuta Y
Rev Gastroenterol Peru; 2004; 24(3):263-9. PubMed ID: 15483687
[TBL] [Abstract][Full Text] [Related]
30. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
Johnson S; Schriever C; Patel U; Patel T; Hecht DW; Gerding DN
Anaerobe; 2009 Dec; 15(6):290-1. PubMed ID: 19698797
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile colitis: an increasing hospital-acquired illness.
Jobe BA; Grasley A; Deveney KE; Deveney CW; Sheppard BC
Am J Surg; 1995 May; 169(5):480-3. PubMed ID: 7747823
[TBL] [Abstract][Full Text] [Related]
32. Nitazoxanide for the treatment of Clostridium difficile colitis.
Musher DM; Logan N; Hamill RJ; Dupont HL; Lentnek A; Gupta A; Rossignol JF
Clin Infect Dis; 2006 Aug; 43(4):421-7. PubMed ID: 16838229
[TBL] [Abstract][Full Text] [Related]
33. Tigecycline for the treatment of severe Clostridium difficile infection.
Larson KC; Belliveau PP; Spooner LM
Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
[TBL] [Abstract][Full Text] [Related]
34. Intracolonic Vancomycin Through Laprascopic Appendicostomy for Treatment of Severe Clostridium difficile Colitis Does Not Get Systemic Absorption.
Alhazmi L; Almeshal N; Assaly R
Am J Ther; 2017; 24(5):e616. PubMed ID: 28301334
[No Abstract] [Full Text] [Related]
35. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
McFarland LV; Elmer GW; Surawicz CM
Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033
[TBL] [Abstract][Full Text] [Related]
36. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.
Ben-Horin S; Margalit M; Bossuyt P; Maul J; Shapira Y; Bojic D; Chermesh I; Al-Rifai A; Schoepfer A; Bosani M; Allez M; Lakatos PL; Bossa F; Eser A; Stefanelli T; Carbonnel F; Katsanos K; Checchin D; Miera IS; Chowers Y; Moran GW;
Clin Gastroenterol Hepatol; 2009 Sep; 7(9):981-7. PubMed ID: 19523534
[TBL] [Abstract][Full Text] [Related]
37. Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
[TBL] [Abstract][Full Text] [Related]
38. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis.
Cherifi S; Robberecht J; Miendje Y
Acta Clin Belg; 2004; 59(4):223-4. PubMed ID: 15597730
[TBL] [Abstract][Full Text] [Related]
39. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
Musher DM; Aslam S; Logan N; Nallacheru S; Bhaila I; Borchert F; Hamill RJ
Clin Infect Dis; 2005 Jun; 40(11):1586-90. PubMed ID: 15889354
[TBL] [Abstract][Full Text] [Related]
40. Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner.
Pant C; Sferra TJ; Deshpande A; Minocha A
Eur J Intern Med; 2011 Dec; 22(6):561-8. PubMed ID: 22075280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
